Merck & Co., Inc. (MRK) News Today → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free MRK Stock Alerts $130.89 -0.84 (-0.64%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 4:24 AM | americanbankingnews.comFY2024 Earnings Forecast for Merck & Co., Inc. Issued By Zacks Research (NYSE:MRK)May 16 at 4:25 PM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Sold by Capital Wealth Planning LLCCapital Wealth Planning LLC lessened its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 27.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,513,495 shares of the company's stock after sellingMay 16 at 1:55 PM | markets.businessinsider.comBank of America Securities Keeps Their Buy Rating on Merck & Company (MRK)May 16 at 8:54 AM | finance.yahoo.comThe Zacks Analyst Blog Highlights Broadcom, Merck, Airbnb, ONEOK and PG&EMay 16 at 8:38 AM | marketbeat.comFY2024 EPS Estimates for Merck & Co., Inc. (NYSE:MRK) Boosted by AnalystMerck & Co., Inc. (NYSE:MRK - Free Report) - Research analysts at Zacks Research upped their FY2024 earnings per share estimates for Merck & Co., Inc. in a research note issued on Wednesday, May 15th. Zacks Research analyst S. Ganoria now anticipates that the company will earn $8.62 per share forMay 16 at 7:08 AM | marketbeat.comMerck & Co., Inc. Q1 Earnings TranscriptMay 16 at 3:54 AM | investing.comMerck & Co Inc BDR (MRCK34)May 16 at 12:46 AM | marketbeat.comFoundations Investment Advisors LLC Sells 21,775 Shares of Merck & Co., Inc. (NYSE:MRK)Foundations Investment Advisors LLC lessened its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 31.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 46,980 shares of the company's stock after selling 21,775 shares during the period.May 15 at 10:35 PM | seekingalpha.comMerck & Co., Inc. (MRK) BofA Securities 2024 Health Care Conference (Transcript)May 15 at 6:45 AM | businesswire.comMerck to Present New Data at 2024 ASCO Annual Meeting Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse PipelineMay 14 at 9:52 PM | marketbeat.comMerck & Co., Inc. (NYSE:MRK) is Empire Life Investments Inc.'s 4th Largest PositionEmpire Life Investments Inc. lessened its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 2.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 478,937 shares of the company's stock after selling 12,7May 14 at 5:08 AM | americanbankingnews.comMerck & Co., Inc. (NYSE:MRK) Given Consensus Rating of "Moderate Buy" by AnalystsMay 13, 2024 | marketbeat.comGratus Capital LLC Increases Holdings in Merck & Co., Inc. (NYSE:MRK)Gratus Capital LLC grew its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 39.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 140,955 shares of the company's stock after purchasing an adMay 13, 2024 | reuters.comMerck stops skin cancer combination therapy testing in late-stage studyMay 13, 2024 | businesswire.comMerck Provides Update on Phase 3 KeyVibe-010 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab as Adjuvant Treatment for Patients With Resected High-Risk MelanomaMay 12, 2024 | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Sold by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA lessened its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 5.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,427,241 shares of the company's stocMay 11, 2024 | marketbeat.comDimensional Fund Advisors LP Sells 2,807,658 Shares of Merck & Co., Inc. (NYSE:MRK)Dimensional Fund Advisors LP lessened its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 32.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,939,525 shares of the coMay 11, 2024 | 247wallst.comJP Morgan Has 5 Blue Chip Passive Income Stocks as Top Picks for MayMay 10, 2024 | marketbeat.comVestor Capital LLC Decreases Position in Merck & Co., Inc. (NYSE:MRK)Vestor Capital LLC trimmed its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 83.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,062 shares of the company's stock after selling 39,427May 10, 2024 | finance.yahoo.comMerck's (NYSE:MRK) investors will be pleased with their notable 90% return over the last three yearsMay 9, 2024 | finance.yahoo.comMerck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly Diagnosed, High-Risk Endometrial Cancer After Surgery With Curative IntentMay 9, 2024 | finance.yahoo.comHealth Canada Approves KEYTRUDA® for adult patients with locally advanced unresectable or metastatic biliary tract carcinoma, in combination with gemcitabine-based chemotherapyMay 9, 2024 | marketbeat.comHi Line Capital Management LLC Has $8.73 Million Stock Position in Merck & Co., Inc. (NYSE:MRK)Hi Line Capital Management LLC lessened its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 8.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 79,468 shares of the company's stock after sellingMay 9, 2024 | reuters.comMerck treatment for a type of uterus cancer fails trialMay 9, 2024 | marketbeat.comWealthspire Advisors LLC Lowers Holdings in Merck & Co., Inc. (NYSE:MRK)Wealthspire Advisors LLC lessened its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 10.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 51,264 shares of the company's stock after selling 6,262 shMay 8, 2024 | finanznachrichten.deMerck & Co., Inc.: Merck Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for MothersMay 8, 2024 | finance.yahoo.comMerck Expands Access to High-Quality Maternal Care for More Than 30 Million Women Worldwide Through Merck for MothersMay 8, 2024 | finance.yahoo.comQ1 2024 OPKO Health Inc Earnings CallMay 8, 2024 | businesswire.comMerck to Participate in the Bank of America Securities 2024 Healthcare ConferenceMay 8, 2024 | marketbeat.comCullen Frost Bankers Inc. Has $36.21 Million Stake in Merck & Co., Inc. (NYSE:MRK)Cullen Frost Bankers Inc. reduced its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 4.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 332,150 shares of the company's stock afterMay 6, 2024 | marketbeat.comWelch & Forbes LLC Trims Stock Holdings in Merck & Co., Inc. (NYSE:MRK)Welch & Forbes LLC trimmed its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 3.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 380,846 shares of the company's stock after seMay 6, 2024 | seekingalpha.comMerck Q1: There's Still Room For GrowthMay 6, 2024 | finance.yahoo.comMerck First Quarter 2024 Earnings: Beats ExpectationsMay 6, 2024 | globenewswire.comPress Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) RegionMay 6, 2024 | marketbeat.comMetis Global Partners LLC Has $15.87 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK)Metis Global Partners LLC boosted its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 13.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 145,574 shares of the company's stock after buying an additional 16,730 shares during the period.May 4, 2024 | marketbeat.comRiver Global Investors LLP Makes New Investment in Merck & Co., Inc. (NYSE:MRK)River Global Investors LLP bought a new stake in Merck & Co., Inc. (NYSE:MRK - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 35,000 shares of the company's stock, valMay 3, 2024 | marketbeat.comLos Angeles Capital Management LLC Boosts Stock Position in Merck & Co., Inc. (NYSE:MRK)Los Angeles Capital Management LLC grew its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 32.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 376,302 shares of the company's stock after buMay 3, 2024 | marketbeat.comFifth Third Bancorp Has $116.35 Million Position in Merck & Co., Inc. (NYSE:MRK)Fifth Third Bancorp grew its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 2.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 881,761 shares of the company's stock after purchasing an additional 19,407May 2, 2024 | finance.yahoo.comMerck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent ExpirationMay 1, 2024 | marketbeat.comFirst Trust Direct Indexing L.P. Has $4.47 Million Holdings in Merck & Co., Inc. (NYSE:MRK)First Trust Direct Indexing L.P. boosted its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 18.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 40,954 shares of the company's stock after acquiring an additMay 1, 2024 | finance.yahoo.comMerck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaMay 1, 2024 | forbes.comIs Merck Stock Fully Valued At $130?May 1, 2024 | marketbeat.comRaymond James Financial Services Advisors Inc. Has $471.70 Million Position in Merck & Co., Inc. (NYSE:MRK)Raymond James Financial Services Advisors Inc. grew its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 0.6% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,574,872 shares of the companyApril 30, 2024 | finance.yahoo.comMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call TranscriptApril 29, 2024 | marketbeat.comKestra Private Wealth Services LLC Purchases 12,477 Shares of Merck & Co., Inc. (NYSE:MRK)Kestra Private Wealth Services LLC increased its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 6.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 215,521 shares of the company's stock after buyingApril 29, 2024 | businesswire.comMerck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for AdultsApril 28, 2024 | marketbeat.comBlue Chip Partners LLC Raises Stock Position in Merck & Co., Inc. (NYSE:MRK)Blue Chip Partners LLC boosted its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 12.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 142,375 shares of the company's stock after purchasiApril 27, 2024 | marketbeat.comMerck & Co., Inc. (NYSE:MRK) Shares Acquired by PFG Investments LLCPFG Investments LLC boosted its position in Merck & Co., Inc. (NYSE:MRK - Free Report) by 172.8% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 62,576 shares of the company's stock after purchasing an additionApril 27, 2024 | finance.yahoo.comMerck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts ThinkApril 27, 2024 | marketbeat.comTruist Financial Corp Reduces Stock Holdings in Merck & Co., Inc. (NYSE:MRK)Truist Financial Corp lessened its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 7.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,771,324 shares of the company's stock after selling 289,465 shares durin Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Americans Now Need $1.46M to Retire… (Ad)Americans now say they need $1.46M in order to “retire comfortably.” For many, retiring in your 60s may be out of the picture altogether… But luckily for you – a limited window in today’s crypto market could help you retire quickly in wealth AND comfort! Click here to access the free Crypto Retirement Blueprint now. MRK Media Mentions By Week MRK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRK News Sentiment▼0.730.54▲Average Medical News Sentiment MRK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRK Articles This Week▼2015▲MRK Articles Average Week Get Merck & Co., Inc. News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Johnson & Johnson News AbbVie News Pfizer News Bristol-Myers Squibb News Eli Lilly and Company News AstraZeneca News Novartis News Abbott Laboratories News Sanofi News Regeneron Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MRK) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck & Co., Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
